Literature DB >> 16372535

Enzastaurin and pemetrexed exert synergistic antitumor activity in thyroid cancer cell lines in vitro.

O Oberschmidt1, U Eismann, L Schulz, S Struck, J Blatter, M M Lahn, D Ma, A R Hanauske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16372535

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN： 0946-1965            Impact factor:   1.366


× No keyword cloud information.
  5 in total

1.  Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation.

Authors:  Christopher D Willey; Dakai Xiao; Tianxiang Tu; Kwang Woon Kim; Luigi Moretti; Kenneth J Niermann; Mohammed N Tawtawy; Chad C Quarles; Bo Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-10       Impact factor: 7.038

2.  Protein kinase C beta in malignant pleural mesothelioma.

Authors:  Leonardo Faoro; Sivakumar Loganathan; Maria Westerhoff; Rahul Modi; Aliya N Husain; Maria Tretiakova; Tanguy Seiwert; Hedy L Kindler; Everett E Vokes; Ravi Salgia
Journal:  Anticancer Drugs       Date:  2008-10       Impact factor: 2.248

3.  Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation.

Authors:  Karen Bräutigam; Dirk Olaf Bauerschlag; Marion Tina Weigel; Julia Biernath-Wüpping; Thomas Bauknecht; Norbert Arnold; Nicolai Maass; Ivo Meinhold-Heerlein
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

4.  MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer.

Authors:  Leonardo Faoro; Gustavo M Cervantes; Benjamin D Ferguson; Tanguy Y Seiwert; Soheil Yala; Wicki T Vigneswaran; Maria Westerhoff; Maria S Tretiakova; Mark K Ferguson; Glaci L Moura; Aliya N Husain; Everett E Vokes; Ravi Salgia
Journal:  J Carcinog       Date:  2009

5.  Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells.

Authors:  C Tekle; E Giovannetti; J Sigmond; J R Graff; K Smid; G J Peters
Journal:  Br J Cancer       Date:  2008-08-19       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.